Orforglipron, an experimental oral GLP-1 receptor agonist, demonstrates potential for long-term weight maintenance in patients transitioning from injectable therapies, according to phase 3b trial data. Results presented in May 2026 …
Tag:
orforglipron
-
-
Orforglipron: Maintaining Weight Loss After Wegovy and Zepbound Table of Contents Orforglipron: Maintaining Weight Loss After Wegovy and Zepbound The Challenge of Weight Regain After GLP-1 Injections ATTAIN-MAINTAIN Study Results: …